Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I.
about
Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapyInterleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expressionMammalian target of rapamycin is essential for cardiomyocyte survival and heart development in miceActivation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells.Neurodevelopmental effects of insulin-like growth factor signaling.Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43.PTEN gene and integrin signaling in cancer.Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cellsTissue-specific Bcl-2 protein partners in apoptosis: An ovarian paradigm.Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis.Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways.Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21Regulation of Id gene expression by type I insulin-like growth factor: roles of Stat3 and the tyrosine 950 residue of the receptor.Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer.Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells.TDAG51 mediates the effects of insulin-like growth factor I (IGF-I) on cell survival.Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.PDGF in gliomas: more than just a growth factor?Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.Increased expression of the Akt/PKB inhibitor TRB3 in osteoarthritic chondrocytes inhibits insulin-like growth factor 1-mediated cell survival and proteoglycan synthesisDifferential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer models.Overview of Transgenic Glioblastoma and Oligoastrocytoma CNS Models and Their Utility in Drug DiscoveryConstitutive ERK MAPK activity regulates macrophage ATP production and mitochondrial integrityCell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival.c-Myb transcription is activated by protein kinase B (PKB) following interleukin 2 stimulation of Tcells and is required for PKB-mediated protection from apoptosis.A kinase-independent role for unoccupied insulin and IGF-1 receptors in the control of apoptosis.NF-kappaB mediates the survival of human bronchial epithelial cells exposed to cigarette smoke extract.Proteomic profiling of the effect of prostate-specific antigen on prostate cancer cells.Grb10 and active Raf-1 kinase promote Bad-dependent cell survival.Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism.Role of transcription factor activator protein 1 (AP1) in epidermal growth factor-mediated protection against apoptosis induced by a DNA-damaging agent.Inhibition of Akt/PKB by a COX-2 inhibitor induces apoptosis in gastric cancer cells.Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52.Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells.Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells.Adenovirus vectors activate survival pathways in lung epithelial cells.Suppression of adriamycin-induced apoptosis by sustained activation of the phosphatidylinositol-3'-OH kinase-Akt pathway.Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571.Head involution defective (Hid)-triggered apoptosis requires caspase-8 but not FADD (Fas-associated death domain) and is regulated by Erk in mammalian cells.Differential roles of insulin receptor substrates in the anti-apoptotic function of insulin-like growth factor-1 and insulin.
P2860
Q22299231-76C8FECB-9394-4C7B-AABC-49D154D858F8Q28190211-C3271F96-74E9-4935-8C1E-1E568BB9D62CQ28593301-438FA9E7-EDA8-45C3-8F9C-EFA96DBEFE54Q30424348-6A7E8181-7160-4559-9B20-4F8CE2E7E2FFQ30451424-C3B4F6D2-E0EC-458A-8C3F-B4CA953E3E93Q33730201-723C05B5-AFBE-403A-9E17-BDB82700A058Q33765703-A30E1CB0-47AA-4F06-8E24-934C45E1C403Q33786993-D81F2C32-4C80-4DBA-96BF-D0D406E460B4Q33881268-DC9D86B2-4897-414D-BB0E-BD09AB2BD167Q33959860-727B8BED-EEC0-4882-81D6-78816A2AA032Q33963275-0A1AE240-9316-4F52-BD33-A3E0BB0A5FF9Q33966727-86C700B4-E8B6-4E7B-A6C2-EBC616C87387Q33969194-76ED616F-0488-4C27-85C8-2CD8247D4274Q34043823-0F96EC6C-DB90-405A-A31F-4FF234FF9F8FQ34132479-4B0D973E-D208-4DA7-91BC-0843C9D409A1Q34307902-6A8A48FD-67D3-4B15-8E0A-428185FDD626Q35221813-4DF2D2D1-7DE0-4948-80CD-EA9583B20121Q35920489-3631F5BC-0EF7-47AF-B7C1-497770A6113CQ36861002-CFDEA128-63F0-447C-AEA6-353CB39B51C6Q37088709-9DA3C1D4-A4FB-4BA4-8B71-19FCED245DA7Q38314947-DA6C4195-8075-4007-993B-66CEE10A5A63Q38781953-191E5224-D66E-4730-B6B8-B33FC16E8959Q38804893-B1C1A001-FBF8-4928-A7F9-B6C2B1470A71Q39446473-55A873C3-B400-4B33-8E83-F4B2E43A1443Q39460797-C65DD95F-1B23-45C3-A802-F5B00AA8E27BQ39622751-BEF986B3-86D1-40AE-A5F5-82076DE87CDDQ39936754-EFC74C05-3B21-4E9B-8FC8-C872A9D6BFF9Q39958485-6DD2421D-C630-4368-9512-A1BCCCA1906AQ40126556-8CCE7369-A68D-46C2-87EC-B0E0FCC9562AQ40219918-A529E390-163A-4E54-9753-228779DAD0BFQ40243480-3CC2A775-16A4-40CB-8C18-3A372BFAE489Q40287095-818080CB-06E6-4A00-913D-968CCBD891C5Q40292772-B4EDA2F2-1222-4983-A6A2-6F04D17ECAC1Q40379423-A5D4A86F-7E22-4E45-9B9B-E469AA89024AQ40446897-3193F7FA-C322-48CF-BAF8-0C9102DD124AQ40563297-16EDB375-8B27-4BCA-934C-54D6D49E6ACAQ40624347-F602D956-F26A-47F6-BBB8-5749E65A8CFBQ40709933-9A86367B-571F-408F-B8B8-2E72B0979C7CQ40717811-8A7D867D-021F-46D3-8A0F-39DDAD6DCAD6Q40722638-4A7B3899-B38B-4BA8-A7B3-A5720B3A61C7
P2860
Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Akt-dependent and -independent ...... insulin-like growth factor I.
@ast
Akt-dependent and -independent ...... insulin-like growth factor I.
@en
type
label
Akt-dependent and -independent ...... insulin-like growth factor I.
@ast
Akt-dependent and -independent ...... insulin-like growth factor I.
@en
prefLabel
Akt-dependent and -independent ...... insulin-like growth factor I.
@ast
Akt-dependent and -independent ...... insulin-like growth factor I.
@en
P2860
P356
P1476
Akt-dependent and -independent ...... insulin-like growth factor I.
@en
P2093
P2860
P304
P356
10.1128/MCB.18.11.6711
P407
P577
1998-11-01T00:00:00Z